A bridge too far? Findings of bridging anticoagulation use and outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 25499874)

Published in Circulation on December 12, 2014

Authors

Amir Y Shaikh¹, David D McManus²

Author Affiliations

1: From the Department of Medicine, University of Massachusetts Medical School, Worcester, MA (A.Y.S., D.D.M.); Division of Cardiology and Electrophysiology, University of Massachusetts Medical School, Worcester, MA (D.D.M.); and Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA (D.D.M.).
2: From the Department of Medicine, University of Massachusetts Medical School, Worcester, MA (A.Y.S., D.D.M.); Division of Cardiology and Electrophysiology, University of Massachusetts Medical School, Worcester, MA (D.D.M.); and Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA (D.D.M.). mcmanusd@ummhc.org.

Associated clinical trials:

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study) | NCT00786474

PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin. | NCT00432796

Articles citing this ↘

[Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions]. Ophthalmologe (2016) 0.75

Articles cited by this ↗

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78

Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med (2013) 6.40

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.29

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation (2012) 3.74

Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol (2012) 3.36

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation (2014) 3.28

Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation (2010) 1.64

Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circulation (2014) 1.47

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost (2014) 1.22

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. J Thromb Haemost (2012) 1.01

Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost (2012) 0.88

Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more). Clin Cardiol (2014) 0.87